المؤلفون: Niglio SA; Department of Hematology and Medical Oncology, Perlmutter Cancer at NYU Langone Health, New York, New York., Purswani JM; Department of Radiation Oncology at NYU Langone Health, New York, New York., Schiff PB; Department of Radiation Oncology at NYU Langone Health, New York, New York., Lischalk JW; Department of Radiation Oncology at NYU Langone Health, New York, New York., Huang WC; Department of Urology, NYU-Langone Health, New York, New York., Murray KS; Department of Urology, NYU-Langone Health, New York, New York., Apolo AB; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.

المصدر: Current opinion in oncology [Curr Opin Oncol] 2024 May 01; Vol. 36 (3), pp. 155-163. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Review; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9007265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-703X (Electronic) Linking ISSN: 10408746 NLM ISO Abbreviation: Curr Opin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Organ Preservation* , Urinary Bladder Neoplasms*/drug therapy, Humans ; Quality of Life ; Biomarkers ; Muscles

المؤلفون: Hurwitz JC; Department of Radiation Oncology, New York University Long Island School of Medicine, Mineola, New York., Haas J; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Mendez C; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Sanchez A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Santos VF; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Akerman M; Division of Health Services Research, New York University Long Island School of Medicine, New York University Langone Health, New York, New York., Carpenter T; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Tam M; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Katz A; Department of Urology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Corcoran A; Department of Urology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, New York, New York., Mahadevan A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, New York., Taneja SS; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, New York., Lepor H; Department of Urology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, New York., Lischalk JW; Department of Radiation Oncology, New York University Long Island School of Medicine, Mineola, New York. Electronic address: jonathan.lischalk@nyulangone.org.

المصدر: Practical radiation oncology [Pract Radiat Oncol] 2024 May-Jun; Vol. 14 (3), pp. 241-251. Date of Electronic Publication: 2023 Nov 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/methods , Radiosurgery*/adverse effects , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/pathology, Humans ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Aged, 80 and over ; Quality of Life ; Prostate/pathology ; Prostate/radiation effects

المؤلفون: Hahnemann L; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Krämer A; Department of Radiation Oncology, University Hospital of Mainz, Langenbeckstraße 1, 55131 Mainz, Germany., Fink C; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Jungk C; Department of Neurosurgery, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Thomas M; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Germany., Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Germany., Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Health at Long Island, New York, NY, USA., Meis J; Institute of Medical Biometry, University of Heidelberg, Im Neuenheimer Feld 130, 69120 Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Eichkorn T; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Deng M; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Lang K; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Paul A; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Meixner E; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Debus J; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology (E050), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., König L; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.

المصدر: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 Apr 21; Vol. 46, pp. 100782. Date of Electronic Publication: 2024 Apr 21 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE

المؤلفون: Deng MY; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Hinz F; Department of Neuropathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Karger CP; Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Sievers P; Department of Neuropathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Hoegen-Sassmannshausen P; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Health at Long Island, New York, New York, USA., Seidensaal K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Bernhardt D; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Jungk C; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Unterberg A; Department of Neurosurgery, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany., Wick A; Department of Neurology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Wick W; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Neurology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., von Deimling A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sahm F; Department of Neuropathology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Combs S; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Apr 05; Vol. 26 (4), pp. 701-712.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Meningioma*/radiotherapy , Meningioma*/surgery , Meningioma*/pathology , Meningeal Neoplasms*/radiotherapy , Meningeal Neoplasms*/surgery, Humans ; Prospective Studies ; Carbon/therapeutic use ; Ions/therapeutic use ; Necrosis/drug therapy ; World Health Organization

المؤلفون: Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: tanja.eichkorn@med.uni-heidelberg.de., Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Health at Long Island, New York, New York., Schwarz R; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Bauer L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Deng M; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Regnery S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Jungk C; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1192-1205. Date of Electronic Publication: 2024 Jan 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Ischemic Stroke*/complications , Stroke*/epidemiology , Stroke*/etiology , Hypertension*/complications , Diabetes Mellitus*, Adult ; Humans ; Male ; Middle Aged ; Protons ; Risk Factors

المؤلفون: Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, 150 Amsterdam Ave., New York, NY, 10023, USA. jonathan.lischalk@nyulangone.org., Sanchez A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA., Santos VF; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, 150 Amsterdam Ave., New York, NY, 10023, USA., Mendez C; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA., Akerman M; Division of Health Services Research, NYU Grossman Long Island School of Medicine, Mineola, NY, 11501, USA., Carpenter T; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA., Tam M; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA., Byun D; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, NY, 10017, USA., Wise DR; Department of Medicine, Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, 10017, USA., Mahadevan A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital, New York, NY, 10017, USA., Evans A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital, New York, NY, 10017, USA., Huang W; Department of Urology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, NY, 10017, USA., Katz A; Department of Urology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA., Lepor H; Department of Urology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, NY, 10017, USA., Haas JA; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital-Long Island, Mineola, NY, 11501, USA.

المصدر: Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 04; Vol. 19 (1), pp. 29. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/adverse effects , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/surgery, Male ; Humans ; Prostate ; Prostate-Specific Antigen ; Biopsy

المؤلفون: Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Akerman M; Division of Health Services Research, New York University Long Island School of Medicine, New York University Langone Health, Mineola, NY, United States., Repka MC; Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, United States., Sanchez A; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Mendez C; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Santos VF; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Carpenter T; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Wise D; Department of Medical Oncology, Perlmutter Cancer Center at New York University Langone Health - Manhattan, New York, NY, United States., Corcoran A; Department of Urology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Lepor H; Department of Urology, Perlmutter Cancer Center at New York University Grossman School of Medicine, New York, NY, United States., Katz A; Department of Urology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States., Haas JA; Department of Radiation Oncology, Perlmutter Cancer Center at New York University Langone Hospital - Long Island, New York, NY, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 Feb 06; Vol. 14, pp. 1325200. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Liu EK; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York., Daniels TB; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York., Lischalk JW; Department of Radiation Oncology, NYU Long Island School of Medicine, Mineola, New York., Oh C; Department of Population Health, NYU Grossman School of Medicine, New York, New York., Haas JA; Department of Radiation Oncology, NYU Long Island School of Medicine, Mineola, New York., Evans AJ; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York., Byun DJ; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York.

المصدر: Urology practice [Urol Pract] 2024 Jan; Vol. 11 (1), pp. 146-152. Date of Electronic Publication: 2023 Nov 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101635343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-0787 (Electronic) Linking ISSN: 23520779 NLM ISO Abbreviation: Urol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Second Primary*/epidemiology , Neoplasms, Radiation-Induced*/diagnosis , Prostatic Neoplasms*/epidemiology, Male ; Humans ; Aged ; Middle Aged ; Prognosis ; Prostate

المؤلفون: Eichkorn T; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. tanja.eichkorn@med.uni-heidelberg.de., Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York, University Langone Health at Long Island, New York, NY, USA., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany., Deng M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Krämer A; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Hoegen P; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Sandrini E; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Regnery S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Held T; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Jungk C; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

المصدر: Journal of neuro-oncology [J Neurooncol] 2023 May; Vol. 162 (3), pp. 489-501. Date of Electronic Publication: 2023 Jan 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Oligodendroglioma*/pathology , Brain Neoplasms*/genetics , Brain Neoplasms*/radiotherapy , Brain Neoplasms*/pathology , Glioma*/genetics , Glioma*/radiotherapy , Astrocytoma*/pathology, Humans ; Aged ; Protons ; World Health Organization ; Isocitrate Dehydrogenase/genetics ; Mutation

المؤلفون: Leu J; Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, United States., Akerman M; Division of Health Services Research, New York University (NYU) Long Island School of Medicine, Mineola, NY, United States., Mendez C; Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States., Lischalk JW; Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States.; NYCyberKnife at Perlmutter Cancer Center - Manhattan, New York, NY, United States., Carpenter T; Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States., Ebling D; Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States., Haas JA; Department of Radiation Oncology, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States.; NYCyberKnife at Perlmutter Cancer Center - Manhattan, New York, NY, United States., Witten M; Department of Medical Physics, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States., Barbaro M; Department of Neurology, New York University (NYU) Long Island School of Medicine, Mineola, NY, United States., Duic P; Department of Neurology, New York University (NYU) Long Island School of Medicine, Mineola, NY, United States., Tessler L; Department of Neurosurgery, Perlmutter Cancer Center at New York University (NYU) Long Island, Mineola, NY, United States., Repka MC; Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.

المصدر: Frontiers in oncology [Front Oncol] 2023 Apr 05; Vol. 13, pp. 1192726. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE